Earnings History Data for Invivyd, Inc. (IVVD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Invivyd, Inc.
INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | IVVD | Invivyd, Inc. | 119.44 | -0.51 | -0.32 | -0.36 | Invivyd GAAP EPS of -$0.51 misses by $0.17, revenue of $9.3M [11/14/2024 7:08 AM] |
0.8018 | -0.09 (-9.91%) |
0.89 | 0.0 (0.00%) |
0.79 - 5.20 | 997,197 | 470,000 | 18,326 | ||
|
||||||||||||||||||
| 09-05-2024 | AH | IVVD | Invivyd, Inc. | 299.25 | -0.38 | -0.50 | -0.32 | Invivyd GAAP EPS of -$0.38 beats by $0.13 [5/9/2024 4:38 PM] |
2.25 | -0.17 (-7.23%) |
2.36 | -0.06 (-2.48%) |
0.98 - 5.20 | 360,846 | 480,000 | 3,873 | ||
| 09-11-2023 | AH | IVVD | Invivyd, Inc. | 163.54 | -0.36 | -0.54 | -0.42 | Adagio Therapeutics GAAP EPS of -$0.36 beats by $0.15 [11/9/2023 4:07 PM] |
1.41 | 0.01 (0.36%) |
1.39 | -0.01 (-0.71%) |
0.98 - 3.79 | 66,733 | 150,000 | 500 | ||
| 10-08-2023 | PM | IVVD | Invivyd, Inc. | 165.32 | -0.46 | -0.40 | -0.47 | Adagio Therapeutics GAAP EPS of -$0.46 misses by $0.11 [8/11/2023 9:55 AM] |
1.60 | 0.05 (3.23%) |
1.67 | 0.12 (7.74%) |
0.98 - 4.90 | 543,164 | 330,000 | 1,784 | ||
| 11-05-2023 | AH | 4:00 PM ET (May 11) |
IVVD | Invivyd, Inc. | 130.09 | -0.32 | -0.36 | -0.93 | Invivyd GAAP EPS of -$0.32 misses by $0.02 [5/11/2023 4:13 PM] |
1.45 | 0.02 (1.40%) |
1.40 | -0.03 (-2.10%) |
1.03 - 4.90 | 231,612 | 240,000 | 6,465 | |
| 23-03-2023 | AH | 4:00 PM ET (Mar 23) |
IVVD | Invivyd, Inc. | 202.71 | -0.41 | -0.39 | -0.77 | Adagio Therapeutics GAAP EPS of -$2.23 [3/23/2023 4:25 PM] |
1.31 | -0.12 (-8.39%) |
1.43 | 0.01 (0.70%) |
1.03 - 6.14 | 408,435 | 280,000 | 121 | |
| 10-11-2022 | AH | After the close (Nov 10) |
IVVD | Invivyd, Inc. | 400.13 | -0.42 | -0.46 | -0.98 | 3.58 | 0.02 (0.56%) |
3.50 | -0.06 (-1.69%) |
2.41 - 78.82 | 408,187 | 270,000 | 1,304 | ||